Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination

Cell Mol Immunol. 2021 Oct;18(10):2455-2456. doi: 10.1038/s41423-021-00755-z. Epub 2021 Aug 23.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Formation
  • BNT162 Vaccine
  • COVID-19 / immunology
  • COVID-19 / prevention & control
  • COVID-19 / virology*
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / immunology
  • ChAdOx1 nCoV-19
  • Female
  • Humans
  • Male
  • SARS-CoV-2 / physiology*

Substances

  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19
  • BNT162 Vaccine